Press Release • Oct 13
The New Yorker Profiled Our Work!
When David Fajgenbaum was a twenty-five-year-old medical student, at the University of Pennsylvania, he started to feel so tired that he could barely stand.
Discover What’s New at
Every Cure
Stay up to date with Every Cure’s latest announcements, research publications, scientific progress, and perspectives on drug repurposing.
News
News, research and progress from Every Cure.
Press coverage, scientific updates, patient impact, and our newsletter archive — all in one place.
Latest news
Press Release • Oct 13, 2026
Every Cure named Overall Winner of Newsweek’s AI Impact Awards
Every Cure, a nonprofit working to reveal the untapped potential of existing medications, has emerged as the overall winner of Newsweek’s inaugural AI Impact Awards.
Press Release • Oct 13, 2026
Every Cure Receives $15M NIH Grant
Funding will directly accelerate our global drug mapping database, ranking 22,000 therapeutics against all human diseases.
Press Release • Jul 21, 2026
Updated NCCN Guidelines Elevate Repurposed Treatment to Preferred Option for Patients with Rosai-Dorfman Disease
Lenalidomide/dexamethasone (len/dex) is now recommended as a preferred treatment option for patients with Rosai-Dorfman Disease regardless of mutation status, potentially expanding access to an effective,
Press Release • Feb 26, 2026
Every Cure Set to Unlock up to $76M from ARPA-H to Advance AI-Identified Drug Repurposing Opportunities Toward Real-World Patient Care
New phase of ARPA-H funding will support preclinical and clinical validation of AI-identified repurposing opportunities, building on earlier work that has already yielded 10 active
Press Release • Jan 9, 2026
Corewell Health, Michigan State University and Every Cure partner so no patient goes undiagnosed
A decades-old drug, long used to treat conditions including a chronic parasitic disease, may soon offer new hope.. Share this